Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: clochard who wrote (977)	6/8/1998 11:58:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 4634

They rely on two very important things: 1) They can claim they are a "development stage company" for years on end. 2) Science illiteracy among many small investors and a surprising number of "analysts".

To: clochard who wrote (977)	6/9/1998 2:25:00 AM
From: Stephen How	Respond to of 4634

Steve, I think that there's more sophistication in the market for things computer (especially hardware) than with biotech. People are very familiar with electronic consumer goods, and probably understand the competitiveness of the market. However, the biotech "story" stocks can take a lot of people for a ride. Witness my favorite biotech at btim.dyn.ml.org I've been arguing my points for 4 months now, and I don't think I've gotten anywhere with the long-oriented boards. Steve